Skip to main content
VERICI DX PLC logo

VERICI DX PLC — Investor Relations & Filings

Ticker · VRCI ISIN · GB00BM8HZD43 LEI · 213800FI5WE4FVQ3G645 IL Real estate activities
Open in API
Filings indexed 189 across all filing types
Latest filing 2023-12-11 Regulatory Filings
Country GB United Kingdom
Listing IL VRCI

About VERICI DX PLC

https://www.vericidx.com/

Verici Dx is an immuno-diagnostics company developing and commercializing a suite of proprietary tests for the kidney transplant market. The company's platform utilizes artificial intelligence-assisted transcriptomic analysis of RNA signatures to provide data-driven insights to clinicians. These tests are designed to decipher the body's immune response and other biological signals, enabling personalized risk assessment for organ injury, rejection, and graft failure. The goal is to assist clinicians in medical management throughout the transplant process, from pre-transplant to late-stage care, ultimately aiming to improve patient outcomes and long-term graft survival.

Recent filings

Filing Released Lang Actions
Tutivia™ validation study published in Journal
Regulatory Filings Classification · 100% confidence The document begins with an 'RNS Number' and is dated '11 December 2023'. It announces that data from a validation study for a product called Tutivia™ has been peer-reviewed and published in 'The American Journal of Transplantation'. The text details the significance of this publication for commercialization and Medicare reimbursement applications. The closing section explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure—a brief announcement about a significant event (like a publication or regulatory filing) disseminated via the RNS system—is characteristic of a general regulatory announcement rather than a full report (like 10-K or IR) or a specific management/financial disclosure. Since it is a regulatory announcement that doesn't fit the more specific categories (like DIV, DIRS, ER, etc.), the most appropriate classification is the general regulatory filing category.
2023-12-11 English
ISO 27001 Information Security Certification
Regulatory Filings Classification · 100% confidence The document is clearly identified as an 'RNS Number' announcement dated November 29, 2023. The content announces that Verici Dx plc has achieved the ISO 27001 certification for its Information Security Management System. This is a specific, non-financial operational update released via the Regulatory News Service (RNS). Since it is a general regulatory announcement that doesn't fit into specific categories like Director's Dealing (DIRS), Earnings Release (ER), or Capital Change (CAP), the most appropriate classification is the general regulatory filing category, RNS.
2023-11-29 English
Investor Presentation
Investor Presentation Classification · 98% confidence The document explicitly states that Verici Dx plc announces that its CEO will provide a live presentation via the Investor Meet Company platform on a specific date. The title of the announcement is 'Investor Presentation'. This directly corresponds to the definition of an Investor Presentation (IP). Although it is distributed via RNS, the core content is the announcement of an investor presentation, not a general regulatory filing or the presentation itself.
2023-11-20 English
Commercialisation agreement with Thermo Fisher
Environmental & Social Information Classification · 99% confidence The document is identified by the 'RNS Number' header and contains a date (15 November 2023) and company information (Verici Dx PLC). The content describes a significant business event: signing an exclusive global licensing agreement with Thermo Fisher Scientific regarding assay technology. This is a material, non-financial announcement disseminated via the Regulatory Information Service (RNS). Since it is a general regulatory announcement that doesn't fit specific categories like M&A (TAR), Capital Change (CAP), or Director Dealing (DIRS), it falls best under the general Regulatory Filings category (RNS). The document length is moderate, but its primary function is to disseminate material news via the RNS system.
2023-11-15 English
Clarava™ poster to be presented at ASN Kidney Week
Legal Proceedings Report Classification · 99% confidence The document is identified by the 'RNS Number' header and contains an announcement about a poster presentation at a medical conference (ASN Kidney Week). It is a brief update regarding company activity (product data presentation) rather than a full financial report (like 10-K or IR) or a formal regulatory filing like a major shareholding change or dividend notice. The presence of the RNS distribution boilerplate at the end strongly suggests it is a general regulatory announcement. Since it is not a specific financial report, management change, or shareholder vote result, the most appropriate general category for this type of market-moving, non-financial-statement announcement is 'Regulatory Filings' (RNS), as it fits the description of a miscellaneous filing that doesn't fit elsewhere, although it is essentially a press release distributed via RNS.
2023-11-02 English
Half-year Report
Interim / Quarterly Report Classification · 100% confidence The document is an announcement from Verici Dx plc regarding its 'unaudited interim results for the six months ended 30 June 2023'. It contains operational highlights, financial highlights (EBITDA, cash balance, cash flow), and a detailed 'Chief Executive Officer's Report'. While it mentions that the full report will be available on the website, the document itself provides the substantive financial data and management analysis for the interim period, qualifying it as an Interim/Quarterly Report (IR) rather than a mere publication announcement. H1 2023
2023-09-29 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.